United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Sells 3,339 Shares of Intuitive Surgical, Inc. $ISRG

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 79,751 shares of the medical equipment provider’s stock after selling 3,339 shares during the period. Intuitive Surgical accounts for 1.7% of United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s portfolio, making the stock its 22nd largest position. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in Intuitive Surgical were worth $43,337,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Nuveen LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $1,715,899,000. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after acquiring an additional 670,302 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after acquiring an additional 584,375 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after acquiring an additional 566,979 shares during the last quarter. Finally, Jennison Associates LLC grew its stake in shares of Intuitive Surgical by 20.4% during the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after purchasing an additional 528,359 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at $3,310,850. This represents a 37.81% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Fredrik Widman sold 2,067 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the completion of the sale, the vice president owned 473 shares in the company, valued at $260,150. This trade represents a 81.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 116,164 shares of company stock worth $61,916,172. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.8%

Shares of NASDAQ:ISRG opened at $574.23 on Thursday. The firm has a market cap of $205.85 billion, a price-to-earnings ratio of 75.96, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company’s fifty day simple moving average is $500.48 and its 200 day simple moving average is $504.89.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the company earned $1.84 EPS. The company’s revenue was up 22.9% on a year-over-year basis. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have weighed in on ISRG shares. Argus increased their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Daiwa Capital Markets upped their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. HSBC increased their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. The Goldman Sachs Group boosted their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.